The Green Rush

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. 

Today we are back with another special hostful episode, a conversation between Lewis Goldberg, KCSA Partner; Phil Carlson, KCSA Managing Director, investor relations; and Kris Krane, KCSA’s Director of Cannabis Development. In this episode, our trio convenes to discuss the recently published U.S. Department of Health and Human Services documents, which recommend to the Drug Enforcement Agency that Cannabis be rescheduled to schedule III.

Listen to our hosts discuss how this will affect the legal cannabis market in the United States, possible implications for cannabis companies, and what the process looks like to move Cannabis from schedule I to schedule III.

If you are interested in learning more about the latest cannabis news, visit the links in our show notes. Also, be sure to follow us on top social media platforms.

So, sit back and enjoy our conversation about the latest news in the cannabis world with Lewis Goldberg, Phil Carlson and Kris Krane of KCSA Strategic Communications.

Links, mentions, and socials:

Show Credits:

This episode was hosted by Lewis Goldberg, Phil Carlson and Kris Krane of KCSA Strategic Communications. 

Special thanks to our Program Director Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

X: @The_GreenRush

Instagram: @thegreenrush_podcast

LinkedIn: linkedin.com/company/thegreenrushpodcast

Facebook: facebook.com/TheGreenRushPodcast 

YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.

This week Anne Donohoe and Nick Opich are back for a new episode with special guest Janet Qi, Co-Founder and CEO of PurMinds NeuroPharma. As our first recorded episode in 2024, Janet joins us this week to discuss her interesting career path which led her to PurMinds, a neuroscience company working with psychedelic compounds to treat neurological disorders.

In this episode, Janet shares more about the specific indications that PurMinds is targeting, like ALS, Parkinson’s and Traumatic Brain Injury; the company’s unique approach to developing these drugs; and highlights on what investors need to know for PurMind’s upcoming $10M Series A raise.

If you are interested in learning more about Janet and PurMinds NeuroPharma, visit the links in our show notes. Also, be sure to follow PurMinds and Janet on LinkedIn and other top social media platforms.

So, sit back and enjoy our conversation with Janet Qi of PurMinds NeuroPharma.

Links, mentions, and socials:

Show Credits:

This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications. 

Special thanks to our Program Director Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

X: @The_GreenRush

Instagram: @thegreenrush_podcast

LinkedIn: linkedin.com/company/thegreenrushpodcast

Facebook: facebook.com/TheGreenRushPodcast 

YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.

This week Nick Opich and Anne Donohoe are back to kick off 2024 with our last recording of 2023. Special guest Dr. Hans Eriksson, Chief Medical Officer for HMNC Brain Health, joins us this week to ring in the New Year, discussing his role at HMNC, the company’s research and development efforts to identify and bring to market treatments for mental health disorders, and the latest news and progress on the psychedelics movement.

In this episode, Hans also discusses the death of the beloved actor Matthew Perry, his ketamine use and how the news was presented by the media, and the risks associated with the treatment.

If you are interested in learning more about Hans or to check out the latest updates from HMNC Brain Health, visit the links in our show notes. Also, be sure to follow HMNC and Hans on LinkedIn.

So, sit back and enjoy our conversation with Dr. Hans Eriksson of HMNC Brain Health.

Links, mentions, and socials:

Show Credits:

This episode was hosted by Nick Opich and Anne Donohoe of KCSA Strategic Communications. 

Special thanks to our Program Director Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

X: @The_GreenRush

Instagram: @thegreenrush_podcast

LinkedIn: linkedin.com/company/thegreenrushpodcast

Facebook: facebook.com/TheGreenRushPodcast 

YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. 

This week Lewis Goldberg, Anne Donohoe, Nick Opich and Kris Krane sit down for an internal hostful conversation as we reflect on 2023 and the evolution of the cannabis and psychedelic spaces. Our four hosts also discuss what they felt were the biggest moments in cannabis and psychedelics in the last year, their thoughts on the potential for rescheduling of cannabis in 2024 and what stories they want to see get more attention in 2024.

For our new followers or ICYMI, check out our refreshed GreenRushPodcast.net website. Revitalized with style, enjoy the ease of locating your favorite episodes from the past and sign up for our Green Rush newsletter, brought back to keep you updated on the latest from the KCSA Green Rush team. 

So, sit back and enjoy our end-of-year hostful episode featuring Lewis Goldberg, Anne Donohoe, Nick Opich and Kris Krane of the Green Rush. 

Links, mentions, and socials:

Show Credits:

This episode was hosted by Lewis Goldberg, Anne Donohoe, Nick Opich and Kris Krane of KCSA Strategic Communications. 

Special thanks to our Program Director Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

Twitter (formerly X): @The_GreenRush 

Instagram: @thegreenrush_podcast

LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/ 

Facebook: https://www.facebook.com/TheGreenRushPodcast/ 

YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. 

This week we are revisiting a conversation our hosts Anne Donohoe and Phil Carlson had earlier this year with Len May, CEO and Co-Founder of Endocanna Health. In that conversation, Len shared how his childhood ADD diagnosis led him to cannabis, then dispensary real estate, and on to launching Endocanna Health. He also covers his company’s DNA test, how they create personalized cannabinoid recommendations, and what’s next for the company and cannabis as a therapeutic.

If you are interested in learning more about Endocanna Health and its testing to deliver personalized guidebooks to the endocannabinoid system, visit the links in our show notes. Also, be sure to follow Len and Endocanna Health on LinkedIn and other top social media platforms.

So, sit back and enjoy our conversation with Len May of Endocanna Health. 

Links, mentions, and socials:

Show Credits:

This episode was hosted by Anne Donohoe and Phil Carlson of KCSA Strategic Communications. 

Special thanks to our Program Director Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

X (formerly Twitter): @The_GreenRush 

Instagram: @thegreenrush_podcast

LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/ 

Facebook: https://www.facebook.com/TheGreenRushPodcast/ 

YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.

This week Anne Donohoe and Lewis Goldberg are back for a new episode with special guest Morgan Paxhia, Co-founder of Poseidon Investment Management. Morgan joins us this week to celebrate Poseidon Investment Management’s 10-year anniversary, detailing the path that led to its founding, sharing some of his favorite accomplishments and plans for the future, as well as his insights and predictions on cannabis rescheduling, the federal banking movement, and investment cycles and opportunities in cannabis.

In this episode, Morgan also outlines Poseidon’s involvement with the David Boies lawsuit in Massachusetts, helping to explain what it means for the cannabis industry and how it could affect the industry as a whole.

If you are interested in learning more about Morgan and his work with Poseidon, visit the links in our show notes. Also, be sure to follow Poseidon and Morgan on top social media platforms.

So, sit back and enjoy our conversation with Morgan Paxhia of Poseidon Investment Management.

Links, mentions, and socials:

Show Credits:

This episode was hosted by Anne Donohoe and Lewis Goldberg of KCSA Strategic Communications. 

Special thanks to our Program Director Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

X (formerly Twitter): @The_GreenRush

Instagram: @thegreenrush_podcast

LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/

Facebook: https://www.facebook.com/TheGreenRushPodcast/ 

YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.

This week Lewis Goldberg and Anne Donohoe are back for a new episode with special guest Ken Jordan, CEO, Co-Founder and Editorial Director of Lucid News. Ken joins us this week to discuss the trajectory of psychedelic mainstreaming and how it’s still affected by the legacy of the Sixties counterculture, plus his experience with plant medicine and how it led to the founding of Lucid News.

In this episode, Ken also emphasizes the importance of education and talks about Lucid’s Psychedelic U Beta, which publishes clear, fact checked articles reviewed by top experts and serves as a starting point for those new to psychedelics as well as experienced psychonauts.

If you are interested in learning more about Ken and Lucid News, visit the links in our show notes. Also, be sure to follow Ken and Lucid on top social media platforms.

So, sit back and enjoy our conversation with Ken Jordan of Lucid News.

Links, mentions, and socials:

Show Credits:

This episode was hosted by Lewis Goldberg and Anne Donohoe of KCSA Strategic Communications. 

Special thanks to our Program Director Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

X (formerly Twitter): @The_GreenRush

Instagram: @thegreenrush_podcast

LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/

Facebook: https://www.facebook.com/TheGreenRushPodcast/ 

YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.

This week Anne Donohoe and Emmaline Lewis are back for a new episode with special guest Dr. Dennis McKenna, Ethnopharmacologist and the Director and President of the McKenna Academy of Natural Philosophy. Dennis joins us this week to discuss his work with the Heffter Research Group and latest projects at the McKenna Academy, including his BioGnosis project in Peru which won “Best Transpersonal Documentary” at the 2023 Psychedelic Film and Music Festival in New York City.

In this episode Dennis shares his insight on the challenges ahead surrounding patient access to psychedelic-assisted therapies, as well as the importance of honoring indigenous knowledge and practices throughout the process of integrating these emerging therapies into the U.S. healthcare system.

If you are interested in learning more about Dennis and the McKenna Academy of Natural Philosophy, visit the links in our show notes. Also, be sure to follow Dennis on LinkedIn and check out his new podcast series, Brainforest Café.

So, sit back and enjoy our conversation with Dr. Dennis McKenna of the McKenna Academy of Natural Philosophy.

Links, mentions, and socials:

Show Credits:

This episode was hosted by Anne Donohoe and Emmaline Lewis of KCSA Strategic Communications. 

Special thanks to our Program Director Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

X (formerly Twitter): @The_GreenRush

Instagram: @thegreenrush_podcast

LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/

Facebook: https://www.facebook.com/TheGreenRushPodcast/ 

YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. 

This week Anne Donohoe and Nick Opich are back for a new episode with special guest Jess Tyler, Chief Revenue and Experience Officer at MJBiz and MJBizCon. Jess joins us this week to discuss what brought her into the cannabis industry and the work that goes into producing the Marijuana Business Conference, the #1 global cannabis business conference and trade show. Held each year at the Las Vegas Convention Center, the 12th-annual MJBizCon will showcase thousands of exhibitors over 3 days complete with pre-show forums and hundreds of industry speakers.

In this conversation, Jess expands upon what to expect at this year’s MJBizCon, including the show’s post-COVID evolution, new installments, and the speakers she’s most excited for, as well as MJBiz’s strategic partnership with re:Mind to produce the Second Annual Psychedelic Business Forum on November 28th and 29th.

If you are interested in learning more about Jess, MJBiz and MJBizCon or the 2023 Psychedelic Business Forum, visit the links in our show notes. Also, be sure to follow Jess and MJBiz on LinkedIn and other top social media platforms.

So, sit back and enjoy our conversation with Jess Tyler of MJBizCon.

Links, mentions, and socials:

Show Credits:

This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications. 

Special thanks to our Program Director Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

X (formerly Twitter): @The_GreenRush

Instagram: @thegreenrush_podcast

LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/

Facebook: https://www.facebook.com/TheGreenRushPodcast/ 

YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. 

This week Nick Opich and Lewis Goldberg are back for a new episode with special guest Brigadier General (Ret.) Stephen N. Xenakis, MD, Executive Director of the American Psychedelic Practitioners Association (APPA). Steve joins us this week to discuss what led him to the military and psychiatry and what it was like taking this path while his peers explored drugs and the counterculture movement, as well as his work with APPA and its publishing of the first professional practice guidelines for psychedelic-assisted therapy practitioners.

In this conversation, Steve also helps us to better understand our veteran and military men and women’s behavioral health needs and how his psychiatric and military expertise uniquely primed him to help APPA in its mission to safely integrate psychedelics into the U.S. healthcare system.

If you are interested in learning more about Steve and the work he’s leading with the team at APPA, visit the links in our show notes. Also, be sure to follow Steve and APPA on LinkedIn and other top social media platforms.

So, sit back and enjoy our conversation with General Xenakis of the American Psychedelic Practitioners Association.

Links, mentions, and socials:

Show Credits:

This episode was hosted by Nick Opich and Lewis Goldeberg of KCSA Strategic Communications. 

Special thanks to our Program Director Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing [email protected]. You can also connect with us via our social channels:

X (formerly Twitter): @The_GreenRush

Instagram: @thegreenrush_podcast

LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/

Facebook: https://www.facebook.com/TheGreenRushPodcast/ 

YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true